Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
9.53
-0.03 (-0.31%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Indivior Revenue
In the year 2024, Indivior had annual revenue of $1.19B with 8.69% growth. Indivior had revenue of $299.00M in the quarter ending December 31, 2024, with 2.05% growth.
Revenue (ttm)
$1.19B
Revenue Growth
+8.69%
P/S Ratio
0.98
Revenue / Employee
$1,130,352
Employees
1,051
Market Cap
1.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.19B | 95.00M | 8.69% |
Dec 31, 2023 | 1.09B | 192.00M | 21.31% |
Dec 31, 2022 | 901.00M | 110.00M | 13.91% |
Dec 31, 2021 | 791.00M | 144.00M | 22.26% |
Dec 31, 2020 | 647.00M | -138.00M | -17.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
INDV News
- 27 days ago - Indivior Announces Further Changes to Board of Directors - PRNewsWire
- 4 weeks ago - UK's Indivior appoints Joe Ciaffoni as CEO - Reuters
- 4 weeks ago - Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - PRNewsWire
- 5 weeks ago - Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection - PRNewsWire
- 5 weeks ago - Indivior PLC (INDV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat - Benzinga
- 5 weeks ago - UK's Indivior forecasts 17% decline in 2025 revenue - Reuters
- 5 weeks ago - Indivior Announces FY and Q4 2024 Financial Results - PRNewsWire